The total serum hexosamine 2 level is elevated in many unrelated chronic diseases (1, 2) , and in experimental animals following acute injury (3, 4) . It is not clear whether this elevation is due to increased production, diminished utilization or merely a shift of tissue hexosamines into the circulation. Since the activity of the adrenal glands is increased in many of these conditions of acute and chronic stress, the role of the adrenal cortex iti sontrclling serum hexosamine levels has been studied. During the course of these studies, it was noted that normal urine contained relatively large amounts of hexosamine, which also increased during conditions of stress. The excretion of hexosamine in the urine in a variety of clinical situations has been measured, therefore, for the purpose of defining factors which alter the rate of its excretion and of correlating excretion levels with changes in serum hexosamine.
An ion exchange technique has been applied to urine hydrolysates for the purpose of separating hexosamines from the many chromogens in urine which interfere with the colorimetric determination of hexosamine (5) . Previously reported studies on urinary hexosamine have not taken this into account and consequently report erroneously high values (6, 7) .
METHODS
All patients selected for urinary hexosamine determinations were free of demonstrable renal disease as indicated by their clinical histories, by blood urea nitrogen determinations, and by routine examination of the urine for cells, casts, and protein. (Table I) . One patient with scleroderma was studied for a period of three months during which time urine volume, hexosamine and creatinine determinations were made. Using the coefficient of variation (V) to compare the variability of these different observations, it can be seen that the excretion of hexosamine was as constant as the excretion of creatinine, despite wide variations in urine volume. A low degree of variability in the excretion of hexosamine was also observed in a patient with rheumatoid arthritis studied for seven consecutive days and in a patient with myxedema studied for two months. There was no apparent influence of the menstrual cycle on the excretion of hexosamine in the urine of two women with scleroderma who had normal cycles and whose daily urine collections had been analyzed for three months.
The hourly excretion rate of hexosamine in the urine was studied in one patient with scleroderma and found to be fairly constant, despite wide variations in the rate of urine formation (Table II) . A reduction in hexosamine excretion during the hours from 8:00 P.M. to midnight was observed on two consecutive days.
Urine hexosamine in chronic diseases
Urinary hexosamine excretion was first studied in normal individuals and later in patients with a variety of chronic diseases in order to assess normal and abnormal excretion limits (Table III) . All of the urine specimens represented 24-hour collections during periods when no medication was being administered, with the exception of a few patients with rheumatoid arthritis who were being (Figure 3 ). This attack was followed by an increase in serum hexosamine which occurred simultaneously with increased excretion of urinary hexosamine and an acceleration of the blood sedimentation rate. Analysis of the electrophoretically separated serum proteins demonstrated that the increase in serum hexosamine was almost entirely confined to the hexosamine in the alpha globulin fractions. No statistically significant changes in the relative amounts of the serum protein fractions were detectable. The attack of gout subsided after 10 days and was followed by a return toward normal of the plasma and urine hexosamine.
Influence of adrenal cortex on serum and urine hexosamine
Since the adrenal glands become physiologically hyperactive following acute injury or stress, and since serum levels and urinary excretion of hexosamine increased following stress, the role of the adrenal cortex as a mediator in this response was considered.
To study serum hexosamine changes in the absence of normal adrenocortical function, a 17-year old boy with known Addison's disease was observed. He entered the hospital in acute Addisonian crisis with a temperature of 1040, due to infectious mononucleosis. His serum hexosamine levels had been normal prior to this admission but became transiently elevated with this acute illness (Figure 1) . The patient died several weeks later To study the effect of adrenal cortical hormones, patients with abnormally elevated serum hexosamine levels were treated with corticotropin or cortisone. Examples in patients with rheumatic fever, rheumatoid arthritis, and lupus erythematosus are shown in Figure 4 . In each instance, hormonal treatment resulted in a transient increase in hexosamine levels followed by a return toward normal, while the hormone was still being given. This is contrary to what one would expect if the adrenal cortex had produced an hexosamine-increasing factor. One normal individual and four patients with hyperthyroidism who had normal hexosamine levels before treatment received corticotropin (100 mg.4 per day for 5 to 10 days) and no changes in hexosamine levels resulted.
The effect of ACTH on the urinary excretion of hexosamine was also studied (Table IV) in two patients each of whom received 100 units of corticotropin daily intramuscularly in divided doses for three days. Patient L. B. was a 45-year old woman with inactive rheumatoid arthritis who was excreting normal amounts of hexosamine. This excretion rate was uninfluenced by corticotropin. The other patient, N. K., a 16-year old boy who was recovering from a leg operation, had an increased rate of excretion of hexosamine before treatment with corticotropin. The urinary 4 Since these experiments were conducted prior to the unit standardization of ACTH, the dosage is expressed in milligrams excretion of hexosamine did not increase further during treatment with corticotropin, but actually appeared to decrease. This is contrary to what one would expect if the adrenal cortex were responsible for the stress induced hexosamine response.
DISCUSSION
Serum hexosamine levels have been reported to be elevated in many unrelated chronic diseases such as leukemia, Hodgkin's disease, carcinomatosis, periarteritis nodosa, rheumatic fever, rheumatoid arthritis, disseminated lupus erythematosus and chronic infections (1, 2, 10) . Serum hexosamine levels have also been found to be elevated following acute diseases such as pneumonia, myocardial infarction (1) and experimental injury to animals (3, 4, 11) .
The data presented here confirm the observations of West and Clarke (1) on myocardial infarction but demonstrate further that other types of unrelated acute diseases and injuries to the body can also induce an increase in serum hexosamine. In one instance (case of gout) the increase in serum hexosamine was found to be in the hexosamines contained in the alpha-globulin fractions. This is consistent with observations that the alphaglobulins (12) and hexosamine-rich alpha-globulin mucoproteins (13, 14) increase in response to other acute injuries or diseases such as burns (12) and pneumonia (13, 14) .
Glucosamine has been identified as an important component of urinary mucus (15, 16) , a carbohydrate-rich material long recognized as a normal constituent of urine (15, 17) . A chemical characterization of most of the glucosamine-containing substances in the urine, however, has not been made. It has recently been shown that approximately 40 per cent of the total urine hexosamine is contained in low molecular weight freely dialyzable substances, and that almost all of the nondialyzable urine hexosamine was found to migrate electrophoretically at pH 8.6 as a single mucoprotein peak (18) which may be similar in part to the urine mucoprotein isolated by Tamm and Horsfall (19) .
It was observed that following acute diseases or body injury, the increased excretion of urine hexosamine coincided in time with the increase seen in serum hexosamine levels. Until the hexosa-mine-containing substances in serum and urine are more clearly identified, however, their physiological relationship cannot be established.
The increase in serum hexosamine levels and in the urinary excretion of hexosamine following acute diseases or injury does not appear to be mediated by the adrenal cortex for the following reasons: 1) A patient with Addison's disease developed a typical increase in serum hexosamine during a crisis, 2) corticotropin or cortisone administration was followed by a reduction in the abnormally elevated hexosamine levels in urine and serum, but had no effect when the urine and serum levels were normal at the start of treatment, 3) plasma hexosamine levels increased following surgical stress in adrenalectomizid rats (20) . The neural or humoral factors responsible for the observed changes in serum and urinary hexosamine following stress are as yet unidentified.
SUMMARY
Serum hexosamine levels increase in response to a variety of acute clinical conditions. This increase was demonstrated following myocardial infarctions, surgical operations, and an acute attack of gout. In the case of gout an increase in the alpha-globulin hexosamines was shown to account for the observed increase in total serum hexosamine.
Excretion of urine hexosamine increased following surgical operations (11) and following an attack of gout.
Corticotropin or cortisone administration was followed by a reduction in the abnormally elevated serum hexosamine levels in rheumatic fever, rheumatoid arthritis, and lupus erythematosus. Corticotropin had no significant effect in five subjects in whom the serum hexosamine levels were normal before treatment. A patient with Addison's disease was able to increase the serum hexosamine level in response to stress.
Corticotropin had no significant effect where the urinary hexosamine excretion was normal before treatment but appeared to diminish the excretion in a case in which the hexosamine had been increased.
The stress-hexosamine response in the serum and urine does not appear to be mediated by the adrenal cortex.
